Octapharma to acquire 33 US plasma centers

Switzerland-headquartered Octapharma, which claims to be the largest, privately-owned plasma products company in the world, says that it will acquire 33 plasma collection centers from International BioResources, the biggest independent source plasma collection company in the USA. The acquisition price was not disclosed.

"Octapharma is committed to serving patient needs around the globe with our product portfolio of plasma derivatives for the treatment of coagulation disorders, immune disease and intensive care and emergency medicines," said the firm's chairman, Wolfgang Marguerre. "In order to fulfil the increasing international demand for our products, we need to source 50% of the plasma needed for our products from Octapharma-owned plasma centers by the next decade," he noted, adding that "IBR will develop and staff the plasma centers with over 800 employees." The facilities will be located predominantly in the East and Midwest.